Swiss pharmaceutical group Roche said Monday it is sticking by its hostile $5.7-billion (4.2 billion euros) bid for US gene mapper Illumina and is extending it for a month.
Feb 27, 2012
0
0
A private firm in Britain was given the green light Thursday to take over the management of a debt-ridden state hospital, in the country's first such deal.
Nov 10, 2011
0
0
Prior knowledge of phase III clinical trials of new drugs and Food and Drug Administration (FDA) regulatory decisions may affect the price of a drug company's stock according to a study published September 26 in the Journal ...
Sep 26, 2011
0
0
